Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 501-520 of 1,550 trials

CMV CTLs in Neonates With CMV Infection

NCT05564598

Patients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened. All patients will receive treatment with valganciclovir or ganciclovir. There is a safety run in with treatment with CMV CTLs in cohort 1 and if found to be safe, will proceed to cohort 2 for randomization to receive antiviral therapy with or without CMV CTLs. Funding source: FDA OOPD

Congenital Cytomegaloviral (CMV) Disease

New York Medical College23 participantsStarted Jul 2023

Los Angeles, California, United States • St Louis, Missouri, United States • Vallhala, New York, United States +1 more locations

RECRUITINGPHASE1< 1 mile

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

NCT04500847

This is a randomized, double-blind clinical trial of a daily oral dose of 200 mg emtricitabine vs. placebo in 35 participants with biomarker-confirmed MCI or mild to moderate dementia due to Alzheimer's disease. Study duration for each subject participating in the placebo-controlled research study will be approximately 12 months (up to a 3 months Screening Period, Baseline visit (1 month), 6 months of placebo or emtricitabine dosing, and 1 month follow-up). Participants will have up to 2 months to complete all procedures for the month 6 study visit.

Alzheimer Disease, Early OnsetMild Cognitive ImpairmentModerate Dementia

Butler Hospital35 participantsStarted Dec 2021

Los Angeles, California, United States • Providence, Rhode Island, United States

CMV CTLs in Neonates With CMV Infection

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Rheumatoid Arthritis Trials in Other Cities

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Distal Targeter vs Free-hand

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

COVID-19 VaccinE Response in Rheumatology Patients

Study of REM-422 in Patients With AML or Higher Risk MDS

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

AltaValve Pivotal Trial

DALY II USA/ MB-CART2019.1 for DLBCL

User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL

Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

Other Conditions in Los Angeles